nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2C19—Prednisone—ankylosing spondylitis	0.072	0.188	CbGbCtD
Escitalopram—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0574	0.15	CbGbCtD
Escitalopram—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0449	0.117	CbGbCtD
Escitalopram—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0435	0.114	CbGbCtD
Escitalopram—CYP3A4—Betamethasone—ankylosing spondylitis	0.0373	0.0976	CbGbCtD
Escitalopram—CYP3A4—Prednisolone—ankylosing spondylitis	0.0368	0.0963	CbGbCtD
Escitalopram—CYP3A4—Prednisone—ankylosing spondylitis	0.0348	0.0909	CbGbCtD
Escitalopram—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0341	0.0893	CbGbCtD
Escitalopram—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0217	0.0568	CbGbCtD
Escitalopram—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000335	0.000542	CcSEcCtD
Escitalopram—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000335	0.000542	CcSEcCtD
Escitalopram—Epistaxis—Methotrexate—ankylosing spondylitis	0.000335	0.000542	CcSEcCtD
Escitalopram—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000335	0.000542	CcSEcCtD
Escitalopram—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000334	0.000542	CcSEcCtD
Escitalopram—Mental disorder—Prednisone—ankylosing spondylitis	0.000334	0.000541	CcSEcCtD
Escitalopram—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000334	0.00054	CcSEcCtD
Escitalopram—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000332	0.000538	CcSEcCtD
Escitalopram—Erythema—Prednisone—ankylosing spondylitis	0.000332	0.000537	CcSEcCtD
Escitalopram—Malnutrition—Prednisone—ankylosing spondylitis	0.000332	0.000537	CcSEcCtD
Escitalopram—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000331	0.000536	CcSEcCtD
Escitalopram—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000331	0.000536	CcSEcCtD
Escitalopram—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00033	0.000535	CcSEcCtD
Escitalopram—Convulsion—Dexamethasone—ankylosing spondylitis	0.00033	0.000535	CcSEcCtD
Escitalopram—Convulsion—Betamethasone—ankylosing spondylitis	0.00033	0.000535	CcSEcCtD
Escitalopram—Hypertension—Dexamethasone—ankylosing spondylitis	0.000329	0.000533	CcSEcCtD
Escitalopram—Hypertension—Betamethasone—ankylosing spondylitis	0.000329	0.000533	CcSEcCtD
Escitalopram—Myalgia—Betamethasone—ankylosing spondylitis	0.000324	0.000525	CcSEcCtD
Escitalopram—Myalgia—Dexamethasone—ankylosing spondylitis	0.000324	0.000525	CcSEcCtD
Escitalopram—Anxiety—Betamethasone—ankylosing spondylitis	0.000323	0.000523	CcSEcCtD
Escitalopram—Anxiety—Dexamethasone—ankylosing spondylitis	0.000323	0.000523	CcSEcCtD
Escitalopram—Discomfort—Betamethasone—ankylosing spondylitis	0.00032	0.000519	CcSEcCtD
Escitalopram—Discomfort—Dexamethasone—ankylosing spondylitis	0.00032	0.000519	CcSEcCtD
Escitalopram—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00032	0.000518	CcSEcCtD
Escitalopram—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000319	0.000517	CcSEcCtD
Escitalopram—Pain—Prednisolone—ankylosing spondylitis	0.000319	0.000516	CcSEcCtD
Escitalopram—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000318	0.000516	CcSEcCtD
Escitalopram—Hepatitis—Methotrexate—ankylosing spondylitis	0.000318	0.000516	CcSEcCtD
Escitalopram—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000316	0.000512	CcSEcCtD
Escitalopram—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000315	0.000509	CcSEcCtD
Escitalopram—Vision blurred—Prednisone—ankylosing spondylitis	0.000313	0.000506	CcSEcCtD
Escitalopram—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000312	0.000506	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000312	0.000506	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000311	0.000504	CcSEcCtD
Escitalopram—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000311	0.000504	CcSEcCtD
Escitalopram—Oedema—Betamethasone—ankylosing spondylitis	0.000311	0.000504	CcSEcCtD
Escitalopram—Oedema—Dexamethasone—ankylosing spondylitis	0.000311	0.000504	CcSEcCtD
Escitalopram—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000311	0.000504	CcSEcCtD
Escitalopram—Insomnia—Triamcinolone—ankylosing spondylitis	0.00031	0.000502	CcSEcCtD
Escitalopram—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000309	0.000501	CcSEcCtD
Escitalopram—Infection—Dexamethasone—ankylosing spondylitis	0.000309	0.0005	CcSEcCtD
Escitalopram—Infection—Betamethasone—ankylosing spondylitis	0.000309	0.0005	CcSEcCtD
Escitalopram—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000308	0.000499	CcSEcCtD
Escitalopram—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000308	0.000498	CcSEcCtD
Escitalopram—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000307	0.000497	CcSEcCtD
Escitalopram—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000307	0.000497	CcSEcCtD
Escitalopram—Visual impairment—Methotrexate—ankylosing spondylitis	0.000307	0.000497	CcSEcCtD
Escitalopram—Anaemia—Prednisone—ankylosing spondylitis	0.000307	0.000497	CcSEcCtD
Escitalopram—Shock—Betamethasone—ankylosing spondylitis	0.000306	0.000495	CcSEcCtD
Escitalopram—Shock—Dexamethasone—ankylosing spondylitis	0.000306	0.000495	CcSEcCtD
Escitalopram—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000305	0.000495	CcSEcCtD
Escitalopram—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000305	0.000494	CcSEcCtD
Escitalopram—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000305	0.000494	CcSEcCtD
Escitalopram—Agitation—Prednisone—ankylosing spondylitis	0.000305	0.000494	CcSEcCtD
Escitalopram—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000304	0.000493	CcSEcCtD
Escitalopram—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000304	0.000493	CcSEcCtD
Escitalopram—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000303	0.000491	CcSEcCtD
Escitalopram—Tachycardia—Betamethasone—ankylosing spondylitis	0.000303	0.000491	CcSEcCtD
Escitalopram—Angioedema—Prednisone—ankylosing spondylitis	0.000303	0.000491	CcSEcCtD
Escitalopram—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000302	0.000488	CcSEcCtD
Escitalopram—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000301	0.000488	CcSEcCtD
Escitalopram—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000301	0.000487	CcSEcCtD
Escitalopram—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000301	0.000487	CcSEcCtD
Escitalopram—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000301	0.000487	CcSEcCtD
Escitalopram—Malaise—Prednisone—ankylosing spondylitis	0.000299	0.000485	CcSEcCtD
Escitalopram—Vertigo—Prednisone—ankylosing spondylitis	0.000298	0.000483	CcSEcCtD
Escitalopram—Eye disorder—Methotrexate—ankylosing spondylitis	0.000298	0.000482	CcSEcCtD
Escitalopram—Syncope—Prednisone—ankylosing spondylitis	0.000297	0.000482	CcSEcCtD
Escitalopram—Tinnitus—Methotrexate—ankylosing spondylitis	0.000297	0.000481	CcSEcCtD
Escitalopram—Anorexia—Betamethasone—ankylosing spondylitis	0.000296	0.00048	CcSEcCtD
Escitalopram—Anorexia—Dexamethasone—ankylosing spondylitis	0.000296	0.00048	CcSEcCtD
Escitalopram—Urticaria—Prednisolone—ankylosing spondylitis	0.000296	0.000479	CcSEcCtD
Escitalopram—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000296	0.000479	CcSEcCtD
Escitalopram—Fatigue—Triamcinolone—ankylosing spondylitis	0.000295	0.000478	CcSEcCtD
Escitalopram—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000295	0.000477	CcSEcCtD
Escitalopram—Pain—Triamcinolone—ankylosing spondylitis	0.000293	0.000475	CcSEcCtD
Escitalopram—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000292	0.000472	CcSEcCtD
Escitalopram—Hypotension—Dexamethasone—ankylosing spondylitis	0.000291	0.00047	CcSEcCtD
Escitalopram—Hypotension—Betamethasone—ankylosing spondylitis	0.000291	0.00047	CcSEcCtD
Escitalopram—Angiopathy—Methotrexate—ankylosing spondylitis	0.000289	0.000468	CcSEcCtD
Escitalopram—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000288	0.000466	CcSEcCtD
Escitalopram—Convulsion—Prednisone—ankylosing spondylitis	0.000287	0.000466	CcSEcCtD
Escitalopram—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000287	0.000465	CcSEcCtD
Escitalopram—Hypertension—Prednisone—ankylosing spondylitis	0.000286	0.000464	CcSEcCtD
Escitalopram—Chills—Methotrexate—ankylosing spondylitis	0.000286	0.000463	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000283	0.000459	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000283	0.000459	CcSEcCtD
Escitalopram—Arthralgia—Prednisone—ankylosing spondylitis	0.000282	0.000457	CcSEcCtD
Escitalopram—Myalgia—Prednisone—ankylosing spondylitis	0.000282	0.000457	CcSEcCtD
Escitalopram—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000282	0.000457	CcSEcCtD
Escitalopram—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000282	0.000456	CcSEcCtD
Escitalopram—Anxiety—Prednisone—ankylosing spondylitis	0.000281	0.000456	CcSEcCtD
Escitalopram—Alopecia—Methotrexate—ankylosing spondylitis	0.000281	0.000456	CcSEcCtD
Escitalopram—Insomnia—Betamethasone—ankylosing spondylitis	0.000281	0.000455	CcSEcCtD
Escitalopram—Insomnia—Dexamethasone—ankylosing spondylitis	0.000281	0.000455	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00028	0.000454	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00028	0.000453	CcSEcCtD
Escitalopram—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000279	0.000452	CcSEcCtD
Escitalopram—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000279	0.000452	CcSEcCtD
Escitalopram—Discomfort—Prednisone—ankylosing spondylitis	0.000279	0.000452	CcSEcCtD
Escitalopram—Mental disorder—Methotrexate—ankylosing spondylitis	0.000279	0.000452	CcSEcCtD
Escitalopram—Malnutrition—Methotrexate—ankylosing spondylitis	0.000277	0.000449	CcSEcCtD
Escitalopram—Erythema—Methotrexate—ankylosing spondylitis	0.000277	0.000449	CcSEcCtD
Escitalopram—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000275	0.000445	CcSEcCtD
Escitalopram—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000274	0.000443	CcSEcCtD
Escitalopram—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000274	0.000443	CcSEcCtD
Escitalopram—Urticaria—Triamcinolone—ankylosing spondylitis	0.000272	0.000441	CcSEcCtD
Escitalopram—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000272	0.00044	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000272	0.00044	CcSEcCtD
Escitalopram—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000271	0.000439	CcSEcCtD
Escitalopram—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000271	0.000438	CcSEcCtD
Escitalopram—Oedema—Prednisone—ankylosing spondylitis	0.000271	0.000438	CcSEcCtD
Escitalopram—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00027	0.000438	CcSEcCtD
Escitalopram—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00027	0.000438	CcSEcCtD
Escitalopram—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00027	0.000438	CcSEcCtD
Escitalopram—Infection—Prednisone—ankylosing spondylitis	0.000269	0.000436	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000268	0.000435	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000268	0.000435	CcSEcCtD
Escitalopram—Back pain—Methotrexate—ankylosing spondylitis	0.000268	0.000434	CcSEcCtD
Escitalopram—Fatigue—Dexamethasone—ankylosing spondylitis	0.000268	0.000434	CcSEcCtD
Escitalopram—Fatigue—Betamethasone—ankylosing spondylitis	0.000268	0.000434	CcSEcCtD
Escitalopram—Shock—Prednisone—ankylosing spondylitis	0.000266	0.000431	CcSEcCtD
Escitalopram—Pain—Betamethasone—ankylosing spondylitis	0.000266	0.000431	CcSEcCtD
Escitalopram—Pain—Dexamethasone—ankylosing spondylitis	0.000266	0.000431	CcSEcCtD
Escitalopram—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000266	0.00043	CcSEcCtD
Escitalopram—Tachycardia—Prednisone—ankylosing spondylitis	0.000264	0.000428	CcSEcCtD
Escitalopram—Skin disorder—Prednisone—ankylosing spondylitis	0.000263	0.000426	CcSEcCtD
Escitalopram—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000262	0.000424	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—ankylosing spondylitis	0.000261	0.000423	CcSEcCtD
Escitalopram—Anorexia—Prednisone—ankylosing spondylitis	0.000258	0.000418	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000257	0.000417	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—ankylosing spondylitis	0.000256	0.000415	CcSEcCtD
Escitalopram—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000256	0.000415	CcSEcCtD
Escitalopram—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000256	0.000415	CcSEcCtD
Escitalopram—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000254	0.000412	CcSEcCtD
Escitalopram—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000254	0.000412	CcSEcCtD
Escitalopram—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000252	0.000409	CcSEcCtD
Escitalopram—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000252	0.000408	CcSEcCtD
Escitalopram—Malaise—Methotrexate—ankylosing spondylitis	0.00025	0.000405	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—ankylosing spondylitis	0.000249	0.000403	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—ankylosing spondylitis	0.000248	0.000402	CcSEcCtD
Escitalopram—Urticaria—Betamethasone—ankylosing spondylitis	0.000247	0.0004	CcSEcCtD
Escitalopram—Urticaria—Dexamethasone—ankylosing spondylitis	0.000247	0.0004	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000247	0.000399	CcSEcCtD
Escitalopram—Dizziness—Prednisolone—ankylosing spondylitis	0.000246	0.000399	CcSEcCtD
Escitalopram—Asthenia—Triamcinolone—ankylosing spondylitis	0.000246	0.000398	CcSEcCtD
Escitalopram—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000246	0.000398	CcSEcCtD
Escitalopram—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000246	0.000398	CcSEcCtD
Escitalopram—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000246	0.000398	CcSEcCtD
Escitalopram—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000246	0.000398	CcSEcCtD
Escitalopram—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000245	0.000397	CcSEcCtD
Escitalopram—Insomnia—Prednisone—ankylosing spondylitis	0.000245	0.000397	CcSEcCtD
Escitalopram—Paraesthesia—Prednisone—ankylosing spondylitis	0.000243	0.000394	CcSEcCtD
Escitalopram—Pruritus—Triamcinolone—ankylosing spondylitis	0.000242	0.000393	CcSEcCtD
Escitalopram—Cough—Methotrexate—ankylosing spondylitis	0.000242	0.000392	CcSEcCtD
Escitalopram—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000242	0.000392	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—ankylosing spondylitis	0.00024	0.000389	CcSEcCtD
Escitalopram—Dyspepsia—Prednisone—ankylosing spondylitis	0.000238	0.000386	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—ankylosing spondylitis	0.000236	0.000382	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—ankylosing spondylitis	0.000236	0.000382	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—ankylosing spondylitis	0.000236	0.000382	CcSEcCtD
Escitalopram—Decreased appetite—Prednisone—ankylosing spondylitis	0.000235	0.000381	CcSEcCtD
Escitalopram—Rash—Prednisolone—ankylosing spondylitis	0.000235	0.00038	CcSEcCtD
Escitalopram—Dermatitis—Prednisolone—ankylosing spondylitis	0.000235	0.00038	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000234	0.00038	CcSEcCtD
Escitalopram—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000234	0.000379	CcSEcCtD
Escitalopram—Fatigue—Prednisone—ankylosing spondylitis	0.000233	0.000378	CcSEcCtD
Escitalopram—Headache—Prednisolone—ankylosing spondylitis	0.000233	0.000378	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—ankylosing spondylitis	0.000233	0.000378	CcSEcCtD
Escitalopram—Constipation—Prednisone—ankylosing spondylitis	0.000232	0.000375	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—ankylosing spondylitis	0.000228	0.00037	CcSEcCtD
Escitalopram—Dizziness—Triamcinolone—ankylosing spondylitis	0.000227	0.000367	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000226	0.000366	CcSEcCtD
Escitalopram—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000226	0.000366	CcSEcCtD
Escitalopram—Infection—Methotrexate—ankylosing spondylitis	0.000225	0.000364	CcSEcCtD
Escitalopram—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000223	0.000361	CcSEcCtD
Escitalopram—Asthenia—Betamethasone—ankylosing spondylitis	0.000223	0.000361	CcSEcCtD
Escitalopram—Asthenia—Dexamethasone—ankylosing spondylitis	0.000223	0.000361	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000222	0.000359	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000222	0.000359	CcSEcCtD
Escitalopram—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000221	0.000359	CcSEcCtD
Escitalopram—Nausea—Prednisolone—ankylosing spondylitis	0.000221	0.000358	CcSEcCtD
Escitalopram—Pruritus—Betamethasone—ankylosing spondylitis	0.00022	0.000356	CcSEcCtD
Escitalopram—Pruritus—Dexamethasone—ankylosing spondylitis	0.00022	0.000356	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—ankylosing spondylitis	0.00022	0.000356	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000219	0.000354	CcSEcCtD
Escitalopram—Vomiting—Triamcinolone—ankylosing spondylitis	0.000218	0.000353	CcSEcCtD
Escitalopram—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000217	0.000352	CcSEcCtD
Escitalopram—Rash—Triamcinolone—ankylosing spondylitis	0.000216	0.00035	CcSEcCtD
Escitalopram—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000216	0.00035	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—ankylosing spondylitis	0.000216	0.000349	CcSEcCtD
Escitalopram—Rash—Methylprednisolone—ankylosing spondylitis	0.000216	0.000349	CcSEcCtD
Escitalopram—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000215	0.000349	CcSEcCtD
Escitalopram—Urticaria—Prednisone—ankylosing spondylitis	0.000215	0.000348	CcSEcCtD
Escitalopram—Headache—Triamcinolone—ankylosing spondylitis	0.000215	0.000348	CcSEcCtD
Escitalopram—Headache—Methylprednisolone—ankylosing spondylitis	0.000214	0.000347	CcSEcCtD
Escitalopram—Abdominal pain—Prednisone—ankylosing spondylitis	0.000214	0.000347	CcSEcCtD
Escitalopram—Body temperature increased—Prednisone—ankylosing spondylitis	0.000214	0.000347	CcSEcCtD
Escitalopram—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000213	0.000345	CcSEcCtD
Escitalopram—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000213	0.000345	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—ankylosing spondylitis	0.000211	0.000342	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000206	0.000334	CcSEcCtD
Escitalopram—Dizziness—Dexamethasone—ankylosing spondylitis	0.000206	0.000333	CcSEcCtD
Escitalopram—Dizziness—Betamethasone—ankylosing spondylitis	0.000206	0.000333	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—ankylosing spondylitis	0.000205	0.000331	CcSEcCtD
Escitalopram—Nausea—Triamcinolone—ankylosing spondylitis	0.000204	0.00033	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000203	0.000329	CcSEcCtD
Escitalopram—Nausea—Methylprednisolone—ankylosing spondylitis	0.000203	0.000329	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000202	0.000327	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—ankylosing spondylitis	0.000201	0.000326	CcSEcCtD
Escitalopram—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000199	0.000323	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000199	0.000323	CcSEcCtD
Escitalopram—Vomiting—Betamethasone—ankylosing spondylitis	0.000198	0.00032	CcSEcCtD
Escitalopram—Vomiting—Dexamethasone—ankylosing spondylitis	0.000198	0.00032	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000197	0.000319	CcSEcCtD
Escitalopram—Rash—Dexamethasone—ankylosing spondylitis	0.000196	0.000317	CcSEcCtD
Escitalopram—Rash—Betamethasone—ankylosing spondylitis	0.000196	0.000317	CcSEcCtD
Escitalopram—Dermatitis—Betamethasone—ankylosing spondylitis	0.000196	0.000317	CcSEcCtD
Escitalopram—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000196	0.000317	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000195	0.000316	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—ankylosing spondylitis	0.000195	0.000316	CcSEcCtD
Escitalopram—Headache—Betamethasone—ankylosing spondylitis	0.000195	0.000315	CcSEcCtD
Escitalopram—Headache—Dexamethasone—ankylosing spondylitis	0.000195	0.000315	CcSEcCtD
Escitalopram—Asthenia—Prednisone—ankylosing spondylitis	0.000194	0.000315	CcSEcCtD
Escitalopram—Pain—Methotrexate—ankylosing spondylitis	0.000193	0.000313	CcSEcCtD
Escitalopram—Pruritus—Prednisone—ankylosing spondylitis	0.000192	0.00031	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000186	0.000302	CcSEcCtD
Escitalopram—Diarrhoea—Prednisone—ankylosing spondylitis	0.000185	0.0003	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000185	0.0003	CcSEcCtD
Escitalopram—Nausea—Betamethasone—ankylosing spondylitis	0.000185	0.000299	CcSEcCtD
Escitalopram—Nausea—Dexamethasone—ankylosing spondylitis	0.000185	0.000299	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—ankylosing spondylitis	0.00018	0.000291	CcSEcCtD
Escitalopram—Dizziness—Prednisone—ankylosing spondylitis	0.000179	0.00029	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000179	0.00029	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000179	0.00029	CcSEcCtD
Escitalopram—Vomiting—Prednisone—ankylosing spondylitis	0.000172	0.000279	CcSEcCtD
Escitalopram—Rash—Prednisone—ankylosing spondylitis	0.000171	0.000276	CcSEcCtD
Escitalopram—Dermatitis—Prednisone—ankylosing spondylitis	0.000171	0.000276	CcSEcCtD
Escitalopram—Headache—Prednisone—ankylosing spondylitis	0.00017	0.000275	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000167	0.00027	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—ankylosing spondylitis	0.000162	0.000263	CcSEcCtD
Escitalopram—Nausea—Prednisone—ankylosing spondylitis	0.000161	0.00026	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—ankylosing spondylitis	0.00016	0.000259	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000155	0.000251	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—ankylosing spondylitis	0.00015	0.000242	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—ankylosing spondylitis	0.000144	0.000233	CcSEcCtD
Escitalopram—Rash—Methotrexate—ankylosing spondylitis	0.000143	0.000231	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—ankylosing spondylitis	0.000143	0.000231	CcSEcCtD
Escitalopram—Headache—Methotrexate—ankylosing spondylitis	0.000142	0.00023	CcSEcCtD
Escitalopram—Nausea—Methotrexate—ankylosing spondylitis	0.000134	0.000218	CcSEcCtD
